Ophthalmic Laser Company Lumenis Receives FDA 510(k) Approval

Lumenis, an Israel-based medical laser company for ophthalmic and surgical applications, received FDA 510(k) clearance for the ResurFX, a fractional non-ablative laser module.

Advertisement

The ResurFX is part of Lumenis’ M22 platform. It uses a 1565 nm fiber laser and CoolScan scanner which create a homogeneous pattern of coagulation columns.

More Articles on Ophthalmology:
UC Irvine to Open $39M Gavin Herbert Eye Institute
7 Statistics on Rewarding Aspects of Ophthalmology Practice
Saratoga Vitreo-Retina Ophthalmology Celebrates 6k Patient Milestone

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in Ophthalmology

  • East Lansing-based Michigan Surgical Center has disclosed a data breach that may have exposed personal information, according to a July…

  • Cincinnati-based MidWest Eye Center welcomed Alec Bradley, MD, an ophthalmologist who specializes in premium cataract surgery, refractive surgery, microinvasive glaucoma…

Advertisement

Comments are closed.